Ovarian reserve is the number of eggs still present in the ovaries; it declines with age and is estimated with an AMH (anti-Müllerian hormone) blood test and an antral follicle count (AFC) on ultrasound. These markers predict response to IVF stimulation well, but on their own they do not predict the chance of natural pregnancy. They must always be interpreted alongside age and the couple's situation.
Ovarian reserve is the stock of oocytes (the cells that will become eggs) in the ovaries at a given time. These oocytes sit inside tiny follicles called primordial follicles.
This stock is formed before birth, during foetal life. After that, it only goes down: each month, a group of follicles is recruited, usually only one reaches ovulation and the others disappear. The decline is slow in early adult life, then speeds up from around 35 until the menopause. Unlike men, who produce sperm continuously, women do not make new eggs.
Some situations can reduce the reserve earlier than expected: ovarian surgery (particularly for an endometrioma, see our endometriosis page), chemotherapy or radiotherapy, smoking, a family history of early menopause, and some genetic or autoimmune causes.
Ovarian reserve cannot be measured directly. It is estimated using hormone and ultrasound markers, ideally combined.
| Test | When? | What it shows | Limitations |
|---|---|---|---|
| AMH (anti-Müllerian hormone), blood test | At any time in the cycle | Reflects the number of small growing follicles; often falls before FSH rises | Lowered by hormonal contraception; varies between laboratories and methods |
| Antral follicle count (AFC), transvaginal ultrasound | Early in the cycle | Number of small follicles visible in both ovaries; closely linked to AMH | Depends on the sonographer and the equipment |
| FSH and oestradiol, blood test | Between day 2 and day 4 of the cycle | A high FSH, especially with an already high oestradiol, suggests reduced reserve | Varies from cycle to cycle; changes late |
The guidelines from the French College of Gynaecologists and Obstetricians (CNGOF, 2022) list the antral follicle count, during the pelvic ultrasound of the fertility work-up, and an AMH test before assisted reproduction among the first-line tests.
No. Ovarian reserve markers tell you about the quantity of eggs, not their quality. And it is mainly egg quality, which depends on age, that determines the chance of pregnancy.
A prospective study published in JAMA in 2017 followed 750 women aged 30 to 44 with no history of infertility. After taking age into account, women with a low AMH (below 0.7 ng/mL) were not less likely to conceive within 12 cycles than women with a normal AMH (84% versus 75%, a difference that was not significant). The same applied to a high FSH.
These markers predict the number of eggs collected after stimulation (ESHRE, 2025), but not natural fertility: the authors of this study conclude that they should not be used as a "fertility test" in a woman who has no difficulty conceiving.
A young woman with a low AMH therefore usually still has a good chance of natural pregnancy. Conversely, a normal AMH at 42 does not make up for the age-related decline in egg quality.
During fertility treatment, ovarian reserve testing is mainly useful to:
A woman described as a "poor responder" to stimulation can still become pregnant: the number of eggs is only one part of the outlook.
What to do depends mainly on your age and your plans:
In IVF, a low reserve leads to an adapted protocol. For lack of sufficient evidence, ESHRE (2025) does not recommend most of the add-on treatments offered to so-called poor responders.
Finally, a low reserve does not necessarily mean the menopause is imminent. If it comes with periods that become less frequent or stop before 40, specific tests look for premature ovarian insufficiency, which needs its own management, particularly to protect the bones and heart.
This is not a screening test to offer every woman. It is useful:
The result should be explained during a consultation: on its own, it can cause needless worry or false reassurance. To book a fertility assessment at the practice, make an appointment on Doctolib or call +33 1 43 79 59 79.
Would you like a medical opinion?Appointments in Paris 16th or 5th, or by video consultation.
Book an appointmentNo treatment, supplement or diet has been shown to increase the number of eggs. You can, however, avoid damaging it, particularly by stopping smoking and discussing the strategy before any ovarian surgery.
It is not essential, but hormonal contraception can lower AMH and the follicle count. Your doctor takes this into account and may suggest repeating the test some time after stopping if the result is low.
It shows a large number of small follicles, which is common with polycystic ovary syndrome. In IVF, it means stimulation must be adjusted to limit the risk of ovarian hyperstimulation.
It gives a trend, but not a reliable date for an individual woman. It should not be used on its own to make decisions about contraception or pregnancy plans.
In France, reimbursement of AMH by the Assurance maladie is restricted to certain indications, notably testing before assisted reproduction. Your doctor or the laboratory can tell you what applies to you.
A question about your situation?Appointments at the practice or by video consultation, usually within one week to 10 days.
Book an appointmentGeneral information article: it does not replace a medical consultation. In an emergency, call 15 or 112 in France, or your local emergency number.